Roche announced that the FDA has approved COBAS TaqMan HIV-1 Test v2.0, a new HIV viral load test that targets two highly conserved regions of the HIV-1 genome and avoids any regions which are current drug targets. This approach provides increased reliability even with rare mismatches in primer/probe binding sites and when mutations are present.
The test utilizes the FDA-approved High Pure System Viral Nucleic Acid Kit for manual specimen preparation and the COBAS TaqMan 48 Analyzer for automated amplification and detection.
The HIV test is expected to be available from Roche later this year.
For more information call (800) 526-1247 or visit www.roche.com.